Gapping up
In reaction to strong earnings/guidance:
- SPNS +4.7%, DK +2.8%, UUUU +1.2%, TSN +1.1%
Select financial related names showing strength:
- FOXA +1% (acquires Credible Labs)
Select metals/mining stocks trading higher:
- HMY +5.3%, AG +4.7%, FSM +4.3%, SBGL +4.2%, GFI +4%, PAAS +3.7%, DRD +3.6%, HL +3.2%, IAG +2.9%, GOLD +2.8%, AUY +2.5%, GDX +2.3%, NEM +2.3%, AU +1.5%, SLV +1.3%
Other news:
- ALLK +70.9% (positive results from Phase 2 randomized, double-blind, placebo-controlled trial of AK002 in patients with eosinophilic gastritis and/or eosinophilic gastroenteritis)
- PRVB +8.9% (granted FDA Breakthrough Therapy Designation to teplizumab for the prevention or delay of clinical type 1 diabetes in individuals at-risk of developing the disease; also files $200 mln mixed securities shelf offering)
- ITCI +7.2% (discloses agreement reached with FDA on submission of additional non-clinical information for NDA review of lumateperone for the treatment of schizophrenia; PDUFA goal date extended three months to December 27)
- ABMD +2.7% (comments on final Medicare payment levels for inpatient hospital discharges for fiscal year 2020)
- APYX +1.2% (received FDA 510(k) clearance to market and sell its next-generation J-Plasma Precise Handpiece)
Analyst comments:
- ATEC +1.7% (initiated with an Overweight at Piper Jaffray)